Literature DB >> 8626367

Psychotic depression.

W Coryell1.   

Abstract

The presence of delusions or hallucinations in major depressive disorder indicates a severe form of that disorder. Compared with patients with nonpsychotic depression, those with psychotic depression have depressive symptoms that are individually more severe. They also are more likely to have hypothalamic-pituitary-adrenal axis hyperactivity and increased ventricular-to-brain ratios. The short- and long-term outcomes for such patients are poor. Findings that this prognostic disadvantage may be permanent and that psychotic features recur at high rates in subsequent episodes indicate that these symptoms in major depressive disorder have a lifelong significance. Although monotherapy with antidepressants may be effective, recovery is more rapid when antidepressants are combined with antipsychotics. Electroconvulsive therapy is particularly effective for psychotic depression. The importance of combination therapy for prophylaxis is unknown.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626367

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

1.  Automated signal generation in prescription-event monitoring.

Authors:  Emma Heeley; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

3.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

4.  Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice.

Authors:  Jun-Sheng Wang; C Lindsay DeVane; B Bryan Gibson; Jennifer L Donovan; John S Markowitz; Hao-Jie Zhu
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

5.  Mining mouse behavior for patterns predicting psychiatric drug classification.

Authors:  Neri Kafkafi; Cheryl L Mayo; Greg I Elmer
Journal:  Psychopharmacology (Berl)       Date:  2014-01       Impact factor: 4.530

6.  Gender differences in patients presenting with a single depressive episode according to ICD-10.

Authors:  Lars Vedel Kessing
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-03       Impact factor: 4.328

7.  Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic.

Authors:  Brandon A Gaudiano; Kristy L Dalrymple; Mark Zimmerman
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 8.  [Core symptoms of depression. Effectiveness of antidepressant therapy].

Authors:  J Damm; D Eser; C Schüle; H-J Möller; R Rupprecht; T C Baghai
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

Review 9.  [Depression and stress: is there an endophenotype?].

Authors:  Andrea Feijo Mello; Mario Francisco Juruena; Carmine M Pariante; Audrey R Tyrka; Lawrence H Price; Linda L Carpenter; Jose Alberto Del Porto
Journal:  Braz J Psychiatry       Date:  2007-05       Impact factor: 2.697

10.  Mood Disorders in Neurologic Illness.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.